AJTCCM requires a Data Availability Statement for all submitted research articles. Information about how access to primary datasets (generated during the study) and referenced datasets (datasets analysed in the study) must be provided.  Where data are publicly available, accession codes or other unique identifiers if relevant must be provided. 

As per the ICJME recommendations for clinical trial data: 

Data sharing statements must indicate the following whether individual deidentified participant data (including data dictionaries) will be shared (“undecided” is not an acceptable answer); what data in particular will be shared; whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism). 

These statements will be published under the header ‘Data Availability Statement’ within the footnotes section of the final published article.